# Heart Failure Mortality Prediction Model Summary

## Executive Summary

This model predicts the likelihood of death (DEATH_EVENT) in heart failure patients using clinical and laboratory features. It demonstrates good discriminatory ability with an AUC of approximately 0.86 and solid overall accuracy around 82%. The underlying data is mostly complete with no missing values, but moderate outliers and anomalies warrant cautious interpretation.

## Performance

- **AUC:** 0.859
- **Accuracy:** 0.817
- **F1 score (positive class):** 0.667

The model shows strong ability to distinguish between patients who survive and those who do not, as indicated by the AUC near 0.86. Accuracy above 80% suggests reliable overall predictions, while the F1 score of 0.67 reflects balanced performance in identifying death events despite class imbalance. These metrics indicate the model is useful but not perfect, especially in correctly identifying positive cases.

## Feature Importance

Feature importance is based on SHAP values, which quantify each feature's contribution to the model's predictions. The most influential feature is 'time', where longer follow-up times are associated with increased risk. Lower 'ejection_fraction' values, indicating poorer heart function, increase mortality risk. Elevated 'serum_creatinine' levels, reflecting kidney function impairment, also raise risk. Older age and presence of diabetes further increase the likelihood of death. Other features like 'sex', 'creatinine_phosphokinase', and 'serum_sodium' have smaller but meaningful impacts on risk prediction.

## Data Quality Considerations

The data quality status is WARN due to moderate concerns. While there are no missing or impossible values, key numeric variables such as 'creatinine_phosphokinase', 'platelets', and 'serum_creatinine' contain notable outliers. Additionally, about 10% of rows were flagged as anomalous by IsolationForest, indicating potential unusual or rare cases. These issues could affect model reliability and generalizability, especially if outliers represent data errors or unrepresentative samples.

## Recommendations

Proceed with using the model but apply caution given the WARN data quality status. Consider implementing robust preprocessing steps to mitigate outlier effects, such as winsorization or robust scaling. Investigate anomalous rows to determine if they reflect valid rare cases or data errors. Monitor model performance on new data and validate predictions clinically. Avoid over-reliance on predictions for borderline cases, and consider integrating clinical judgment especially when features show extreme values.
